OBJECTIVES: To define the performance characteristics of the Focus ELISA HSV-1 and HSV-2 assay among 100 university students. STUDY DESIGN: HSV-1 and HSV-2 Focus ELISA and Western Blot assays were performed on sera from university students who reported no history of genital herpes. RESULTS: HSV-2 and HSV-1 seroprevalence by Western Blot were 3.4% and 48%, respectively. In this population, the positive predictive value of the Focus HSV-2 ELISA was 37.5%, the sensitivity was 100%, and specificity was 94.1%. The PPV of the Focus HSV-1 ELISA was 96.7%, the sensitivity was 69.0%, and the specificity was 97.8%. CONCLUSIONS: In this low-prevalence population, the positive predictive value of the Focus HSV-2 ELISA test was low. This finding, together with those reported elsewhere, indicates that caution is warranted when recommending HSV screening in low-prevalence or heterogeneous populations. Consideration should be given to raising the cutoff index value for defining a positive test result.
OBJECTIVES: To define the performance characteristics of the Focus ELISA HSV-1 and HSV-2 assay among 100 university students. STUDY DESIGN:HSV-1 and HSV-2 Focus ELISA and Western Blot assays were performed on sera from university students who reported no history of genital herpes. RESULTS:HSV-2 and HSV-1 seroprevalence by Western Blot were 3.4% and 48%, respectively. In this population, the positive predictive value of the Focus HSV-2 ELISA was 37.5%, the sensitivity was 100%, and specificity was 94.1%. The PPV of the Focus HSV-1 ELISA was 96.7%, the sensitivity was 69.0%, and the specificity was 97.8%. CONCLUSIONS: In this low-prevalence population, the positive predictive value of the Focus HSV-2 ELISA test was low. This finding, together with those reported elsewhere, indicates that caution is warranted when recommending HSV screening in low-prevalence or heterogeneous populations. Consideration should be given to raising the cutoff index value for defining a positive test result.
Authors: Rutger F Nieuwenhuis; Gerard J J van Doornum; Paul G H Mulder; H A Martino Neumann; Willem I van der Meijden Journal: Acta Derm Venereol Date: 2006 Impact factor: 4.437
Authors: Julia Ann Schillinger; Fujie Xu; Maya Raquel Sternberg; Gregory Lee Armstrong; Francis Kwokshun Lee; Andre Joseph Nahmias; Geraldine Marie McQuillan; Michael Ernest Louis; Lauri Ellen Markowitz Journal: Sex Transm Dis Date: 2004-12 Impact factor: 2.830
Authors: Matthew R Golden; Rhoda Ashley-Morrow; Paul Swenson; Wayne R Hogrefe; H Hunter Handsfield; Anna Wald Journal: Sex Transm Dis Date: 2005-12 Impact factor: 2.830
Authors: Esther E Freeman; Helen A Weiss; Judith R Glynn; Pamela L Cross; James A Whitworth; Richard J Hayes Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: J S Smith; R C Bailey; D J Westreich; I Maclean; K Agot; J O Ndinya-Achola; W Hogrefe; R A Morrow; S Moses Journal: Sex Transm Infect Date: 2008-10-27 Impact factor: 3.519
Authors: Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman Journal: J Am Coll Health Date: 2008 Nov-Dec
Authors: Bridget Leyland; Margaret R Kennedy; Yolanda H Wimberly; Bruce J Levine; Thomas L Cherpes Journal: J Clin Virol Date: 2009-01-07 Impact factor: 3.168